Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Psyence cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at our federally licensed ISO22000 facility in Southern Africa. This product is produced for export to our partners across the world to beprocessed into a standardised encapsulated product.
| Last: | $2.52 |
|---|---|
| Change Percent: | -1.95% |
| Open: | $2.62 |
| Close: | $2.57 |
| High: | $2.68 |
| Low: | $2.5 |
| Volume: | 19,261 |
| Last Trade Date Time: | 02/27/2026 12:21:51 pm |
| Market Cap: | $3,250,523 |
|---|---|
| Float: | 1,022,177 |
| Insiders Ownership: | N/A |
| Institutions: | 4 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.psyencebiomed.com |
| Country: | CA |
| City: | Toronto |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Psyence Biomedical Ltd. (NASDAQ: PBM).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
